Multiparametric approach to assess the disease severity and progression of cutaneous leishmaniasis infection

Acta Trop. 2022 Nov:235:106659. doi: 10.1016/j.actatropica.2022.106659. Epub 2022 Aug 18.

Abstract

The pathophysiology of Cutaneous Leishmaniasis (CL), an infection caused by Leishmania tropica (L. tropica) and Leishmania major (L. major) is primarily determined by inflammation-mediated immune cells. The immune response mainly depends on cells and molecules related to T-cells that influence susceptibility and disease development. Understanding the immunological mechanisms that cause tissue injury or lesion healing is critical for developing appropriate treatment strategies. In the present study, T-cells profile and cell-free mitochondrial DNA (CF mt-DNA) were investigated in CL patients infected with L. tropica (n = 34) and L. major (n = 2) and compared with non-infected healthy controls (n = 20). There was a significant (p<0.0001) difference between CD4+ T-cells among L. tropica and L. major CL-infected groups as compared to control while no significant difference (p = 0.8597) was found in the percentages of CD8+ T-cells. When L. tropica and L. major CL-infected individuals were compared to controls, the levels of IL-4 and expression of CF mt-DNA were significantly higher (p<0.0001). Higher levels of CF mt-DNA were detected in CL patients, irrespective of the infective Leishmania species. We proposed that the levels of CF mt-DNA and IL-4 in CL-infected individuals can be used to determine the disease progression. A better understanding of these biomarkers and evaluation of the immune responses in CL patients might benefit the development of vaccines and immunotherapies.

Keywords: Apoptosis; Cell-free mitochondrial DNA; Cutaneous leishmaniasis; IL-4; Mononuclear cells; Prognosis marker.

MeSH terms

  • DNA
  • Humans
  • Interleukin-4
  • Leishmania tropica* / genetics
  • Leishmaniasis, Cutaneous*
  • Severity of Illness Index

Substances

  • IL4 protein, human
  • Interleukin-4
  • DNA